Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma. - Wikidata - thesis-toulmin - TriplyDB

Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma.

Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q36232448

about

MicroRNA in Metabolic Re-Programming and Their Role in Tumorigenesis The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma Exosomes as miRNA Carriers: Formation-Function-Future Role of stem cell-derived exosomes in cancer.Engineering Exosomes for Cancer Therapy.Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells.Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis.Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models Lung tumor exosomes induce a pro-inflammatory phenotype in mesenchymal stem cells via NFκB-TLR signaling pathway Monoacylglycerol lipase promotes progression of hepatocellular carcinoma via NF-κB-mediated epithelial-mesenchymal transition How Do Mesenchymal Stem Cells Influence or Are Influenced by Microenvironment through Extracellular Vesicles Communication?Exosomes: small vesicles with big roles in hepatocellular carcinoma.Extracellular vesicles-mediated noncoding RNAs transfer in cancer.Association of Genetic Polymorphisms in the LncRNAs with Gastric Cancer Risk in a Chinese Population.Motile hepatocellular carcinoma cells preferentially secret sugar metabolism regulatory proteins via exosomes.Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine.Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases.Achieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic Loading.The emerging roles of exosomes in tumor-stroma interaction.Stem cell-based therapies for tumors in the brain: are we there yet?Functions of Exosomes and Microbial Extracellular Vesicles in Allergy and Contact and Delayed-Type Hypersensitivity.Extracellular vesicles in liver diseases.Exosome-derived microRNAs in cancer metabolism: possible implications in cancer diagnostics and therapy.Exosome-Based Cancer Therapy: Implication for Targeting Cancer Stem Cells.MiR-122 modification enhances the therapeutic efficacy of adipose tissue-derived mesenchymal stem cells against liver fibrosis.Extracellular Vesicles from Adipose Tissue-A Potential Role in Obesity and Type 2 Diabetes?Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation.Cross Talk between Adipose Tissue and Placenta in Obese and Gestational Diabetes Mellitus Pregnancies via Exosomes.The crosstalk between autophagic and endo-/exosomal pathways in antigen processing for MHC presentation in anticancer T cell immune responses Extracellular vesicle-mediated transport of non-coding RNAs between stem cells and cancer cells: implications in tumor progression and therapeutic resistance.Mechanisms of Drug Resistance in Cancer: The Role of Extracellular Vesicles.A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies.Chemoresistance in cancer cells: exosomes as potential regulators of therapeutic tumor heterogeneity.Concise Review: Extracellular Vesicles Overcoming Limitations of Cell Therapies in Ischemic Stroke.Exosomes Serve as Nanoparticles to Deliver Anti-miR-214 to Reverse Chemoresistance to Cisplatin in Gastric Cancer.Sorafenib response in hepatocellular carcinoma: MicroRNAs as tuning forks.Role of exosomes and exosomal microRNAs in hepatocellular carcinoma: Potential in diagnosis and antitumour treatments (Review).The Double Face of Exosome-Carried MicroRNAs in Cancer Immunomodulation.Exosomal miRNAs in hepatocellular carcinoma development and clinical responses.Exosomes as a novel pathway for regulating development and diseases of the skin.

P2860

Q26746958-6060DA20-AE2E-4829-B825-C856D9CA7688 Q28066407-D6F60C9C-4112-4FDD-B36E-23C1635B02D7 Q28075728-0C9042C7-AB87-4C4A-870C-1B606381024C Q33684644-1300F121-2AED-48D2-85B8-1406C5BB28BB Q33838411-65A4CFB4-9BDD-427E-A3B1-950EC52D4263 Q33893235-2FD4C78B-BB29-4FC4-A1B1-44A8B486ECF9 Q36553208-751CB30C-7EDE-4CC7-BE0F-D2AEEB145534 Q36668116-385C1ACE-F861-440D-94D0-17E3523C329C Q36811167-4E5BE456-ACC6-462E-B286-BB3078F5CC0C Q37440060-E6854DDE-0A01-4B5F-9E24-7FC51E79B660 Q37627116-BD61C9A0-44E2-415E-A902-95FFC6702D11 Q37645086-FFA391A1-76FD-4BC7-BD18-0D3320A61D4F Q37663393-18EDAD01-0BDB-433E-BE11-C921A4086FFD Q37726374-A8273891-5FF2-49B3-B62C-6A5D83275079 Q38432667-8789E88B-8CBB-42F3-BBD2-3EE6CAC1BB5C Q38608414-43A78BE5-3AB6-40EA-818B-2791BCA78E84 Q38670442-7A9B7C2D-6E31-49B3-BA9A-16C37BEDFE55 Q38743388-1FE5CBFB-24F8-4B86-915E-FB7E919CC464 Q38778513-2F65748A-2D4E-4748-9FC9-81E635F7FB96 Q38855638-0F1098F0-3173-497C-8F1A-2D02F946605D Q39002019-8A2B974B-FC4C-40DD-821D-BBAEB730C08B Q39063293-F59898B8-025B-4D44-93D1-DBFBAABB7E3A Q39095744-34B3F76A-1A11-4CE9-AC4F-5A9848A1DE27 Q39105855-DCF6CCCA-5251-4FEA-97B8-6F92795FF4F0 Q40198585-25B35FC8-E9C3-49B2-99EC-EF5621223704 Q41463093-4397C0BD-49EF-48A2-951E-E846AA91465C Q42099033-66AD435C-3710-4AA0-AE8B-AC282A1DEBB5 Q42288208-8AF996AA-8D1C-4842-BA08-C433429AD97F Q42654753-F2E6B862-0ED6-4B7B-A548-78A1C8EE1B73 Q45338563-16B04BF0-F6B4-4754-AC5F-767BA0F857CA Q46088676-DD1F4CFC-540D-4734-8DF6-2749F3A66329 Q47105314-359B9780-6230-435E-91BA-3074C4F188D8 Q47957249-C8452DAF-9976-43D2-9606-BBD6FFBE85D0 Q48100040-A3098F15-0D2C-479B-90B4-D346CC0E2000 Q49886928-0DF1FB2C-756E-48B2-BECF-149F1C5EB9D1 Q50063114-06A1CD42-2AB6-48C7-9DEB-68C18FF9F76D Q50067800-6C98B74B-D667-4132-8806-6BBE5BCE2E90 Q52589944-5950F55A-3A49-4D03-9694-F1F4F1C9C2AF Q52593381-ACB94B1F-F8E7-4321-AF86-4CCDFD2168E3 Q52620359-C0BB047C-6C1D-4A83-BF39-F05EB1CA55BE

P2860

Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q36232448

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Exosomes derived from miR-122- ...... y of hepatocellular carcinoma.

@ast

Exosomes derived from miR-122- ...... y of hepatocellular carcinoma.

@en

type

label

Exosomes derived from miR-122- ...... y of hepatocellular carcinoma.

@ast

Exosomes derived from miR-122- ...... y of hepatocellular carcinoma.

@en

prefLabel

Exosomes derived from miR-122- ...... y of hepatocellular carcinoma.

@ast

Exosomes derived from miR-122- ...... y of hepatocellular carcinoma.

@en

P1433

Q36232448-0C3D7AB0-12BC-480D-948C-BB40CC5DC430

P1476

Q36232448-BE441F1C-64A3-4289-A0E8-0F85513ADFD4

P2093

Q36232448-3F94351A-F548-41AD-B2EA-0E9E843EF70F

Q36232448-47C0BA13-3AAC-42C9-BFE9-AA7B4B288BF2

Q36232448-78F17688-3264-4AE1-9833-597053F22419

Q36232448-7ADDD98F-D1C5-42C0-BF84-66CA95FE8418

Q36232448-C78632A6-5C48-4C39-9AB8-62FCB9B6D3B2

Q36232448-CE091D74-CDE5-4C05-9817-D25C6F6C435F

Q36232448-EEC913FD-0BCE-4469-87AF-C1A846406750

P2860

Q36232448-165149D9-FF59-41DB-9C1C-0AD80E46B4AA

Q36232448-1A60EABE-479E-4A2A-B5CB-7224607DB971

Q36232448-2B581678-D2DC-4A4B-988C-AD9D9864FAE5

Q36232448-2D8D63DA-7F0A-4E65-A4C4-832E622977DF

Q36232448-2F8D6676-B1F2-41C0-9905-F770DE857514

Q36232448-4CBD685A-52DB-4C00-8F65-E43B70E0FB59

Q36232448-531C6A45-877B-4DBB-8DFD-4865592301B0

Q36232448-58D0789C-DF86-4C96-91D0-EA8A2058E1F3

Q36232448-5A5F3E0D-355B-4AA7-BF65-2912474E92F2

Q36232448-6EA9F259-A18F-473C-9CAD-669F84894523

P2888

Q36232448-A11D03D4-7B94-41C2-B02D-8049AE52DF27

P304

Q36232448-6978408D-1513-4A47-A78C-11EF543AA989

P31

Q36232448-DD3AF9B5-FA70-47CC-81B4-CEBEB528B006

P356

Q36232448-431FBE50-B4D2-473A-B936-42EC85030CAB

P478

Q36232448-8802B64B-2DE4-47FA-A79C-967297346A65

P577

Q36232448-8A2B4CCA-D3B9-4BC1-9F8A-67B836A1121E

P6179

Q36232448-D4DC9FDE-0FEC-4271-B886-B5DCD8D3836E

P698

Q36232448-9FF14BC7-8122-4818-81E6-FA0FB713BD24

P932

Q36232448-7D42FEBC-353C-48FC-960A-2D6849330815

P356

S13045-015-0220-7

P1433

Journal of Hematology & Oncology

P1476

Exosomes derived from miR-122- ...... y of hepatocellular carcinoma.

@en

P2093

Fan Yang

http://www.w3.org/2001/XMLSchema#string

Guohua Lou

http://www.w3.org/2001/XMLSchema#string

Jing Wang

http://www.w3.org/2001/XMLSchema#string

Shanshan Wu

http://www.w3.org/2001/XMLSchema#string

Xiuli Song

http://www.w3.org/2001/XMLSchema#string

Yanning Liu

http://www.w3.org/2001/XMLSchema#string

Zhi Chen

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib

The roles of mesenchymal stem cells in tumor inflammatory microenvironment

Long non-coding RNA: a new player in cancer

Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

Potentiating the efficacy of molecular targeted therapy for hepatocellular carcinoma by inhibiting the insulin-like growth factor pathway

Management of hepatocellular carcinoma

Strategies for modern biomarker and drug development in oncology.

Arsenic trioxide induces differentiation of CD133+ hepatocellular carcinoma cells and prolongs posthepatectomy survival by targeting GLI1 expression in a mouse model

Implication of microRNAs in drug resistance for designing novel cancer therapy

P2888

s13045-015-0220-7

P304

122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13045-015-0220-7

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1024992917

http://www.w3.org/2001/XMLSchema#string

P698

26514126

http://www.w3.org/2001/XMLSchema#string

P932

4627430

http://www.w3.org/2001/XMLSchema#string